VOLUME 6 , ISSUE 1 ( January-June, 2019 ) > List of Articles
Manjeet Singh, Ashwani Ummat, Chetan Sharma, Praveen S Thivari, Sonia Kochhar
Keywords : Chronic plantar fasciitis, Corticosteroid, Platelet-rich plasma
Citation Information : Singh M, Ummat A, Sharma C, Thivari PS, Kochhar S. Efficacy of Platelet-rich Plasma vs Corticosteroid Injection in Chronic Plantar Fasciitis: A Comparative Study. J Foot Ankle Surg Asia-Pacific 2019; 6 (1):2-6.
DOI: 10.5005/jp-journals-10040-1097
License: CC BY-NC 4.0
Published Online: 01-06-2019
Copyright Statement: Copyright © 2019; The Author(s).
Introduction: Chronic plantar fasciitis (PF) is the most common cause of foot complaints making up to 11–15% of the foot symptoms requiring professional care among adults. Also, it is a common problem that affects sport participants as well as inactive middle-aged individuals. The purpose of this study was to compare the effect of steroid and platelet-rich plasma (PRP) in chronic PF. The results were assessed by comparing American orthopedic foot and ankle scale (AOFAS) and visual analogue scale (VAS) before injection, 1, 2, and 6 months after injection in both groups comprising 25 patients in each group. Results: In our study of 50 patients, in steroid group-A, there is significant change in mean VAS from 6.28 ± 0.86 before follow-up injection to 2.8 ± 0.76 in first follow-up visit (1 month after injection) and to 2.92 ± 0.75 in second follow-up visit (2 months after 1st injection) and remained constant at 2.92 + 0.75 at third follow-up (6 months post 1st injection) and significant change in mean AOFAS from 67 ± 10 before injection to 85.76 ± 5.44 in first follow-up visit (1 month after injection) and to 84.16 + 5.94 in second follow-up visit (2 months after first injection) and deteriorated further to 83.92 + 5.84 at third follow-up (6 months after first injection). In 25 patients in group B, there is significant change in mean VAS from 5.8 ± 80.78 before follow-up injection to 1.96 ± 0.45 in first follow-up visit (1 month after injection) and to 1.96 ± 0.45 in second follow-up visit (2 months after first injection) and remained constant at 1.96 ± 0.45 at third follow-up (6 months post first injection) and significant change in AOFAS from 68.44 ± 17.78 before injection to 89.56 ± 0.91 in first follow-up visit (1 month after injection) and to 89.84 ± 0.55 in second follow-up visit (2 months after first injection) and improved further to 89.92 ± 0.40 at third follow-up (6 months after first injection). Conclusion: PRP injection is more effective than corticosteroid injection in the treatment of chronic PF in the long run.
© Jaypee Brothers Medical Publishers (P) LTD.
We use cookies on this site to enhance your user experience.
By clicking any link on this page you are giving your consent for us to set cookies.